J&J single-shot COVID-19 vaccine shows early promiseJ&J has announced early trial results that suggest its single-shot coronavirus vaccine provides a sustained response against the Share XJ&J single-shot COVID-19 vaccine shows early promisehttps://pharmaphorum.com/news/early-data-backs-jjs-single-shot-coronavirus-vaccine-phase-3-results-due-soon/
IO Biotech raises $155m to develop breakthrough cancer vaccineIO Biotech, an oncology specialist formed and backed by Denmark’s Novo Holdings, has raised €127 million ($155 million) Share XIO Biotech raises $155m to develop breakthrough cancer vaccinehttps://pharmaphorum.com/news/io-biotech-raises-155m-to-develop-breakthrough-cancer-vaccine/
UK promises ‘uplift’ in COVID-19 vaccinations as crisis deepensThe UK government has promised a “massive uplift” in the number of coronavirus vaccinations carried out this week, Share XUK promises ‘uplift’ in COVID-19 vaccinations as crisis deepenshttps://pharmaphorum.com/news/uk-promises-uplift-in-covid-vaccinations-as-crisis-deepens/
FDA and doctors warn against extending COVID-19 vaccine dose gapTinkering with the dosing schedule of COVID-19 vaccines runs a “significant risk” to public health, the FDA has Share XFDA and doctors warn against extending COVID-19 vaccine dose gaphttps://pharmaphorum.com/news/fda-and-doctors-warn-against-extending-covid-19-vaccine-dose/
UK rolls out Oxford Uni/AZ COVID-19 shot as cases soarThe first people are receiving the COVID-19 vaccine from Oxford University and AstraZeneca in the UK, as prime Share XUK rolls out Oxford Uni/AZ COVID-19 shot as cases soarhttps://pharmaphorum.com/news/uk-rolls-out-oxford-uni-az-covid-19-shot-as-cases-soar/
UK prepares for decision on AZ/Oxford vaccine as COVID cases soarThe UK’s COVID-19 vaccination programme could get a speed boost, with the country’s drugs regulator expected to make Share XUK prepares for decision on AZ/Oxford vaccine as COVID cases soarhttps://pharmaphorum.com/news/uk-prepares-for-decision-on-az-oxford-shot-as-covid-cases-soar/
‘Highly likely’ BioNTech vaccine will work against new strain, says CEOBioNTech CEO Ugur Sahin has said that it is “highly likely” the company’s COVID-19 vaccine will work against Share X‘Highly likely’ BioNTech vaccine will work against new strain, says CEOhttps://pharmaphorum.com/news/highly-likely-biontech-vaccine-will-work-against-new-strain-says-ceo/
Moderna and BioNTech – who are they?Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA Share XModerna and BioNTech – who are they?https://pharmaphorum.com/views-and-analysis/moderna-and-biontech-who-are-they/
NHS pilots virtual assistant for flu jab bookingsMore than 1,000 NHS patients have booked flu vaccinations using a virtual assistant as part of a pilot Share XNHS pilots virtual assistant for flu jab bookingshttps://pharmaphorum.com/news/nhs-pilots-virtual-assistant/
